S

Shanghai MicuRx Pharmaceutical Co Ltd
SSE:688373

Watchlist Manager
Shanghai MicuRx Pharmaceutical Co Ltd
SSE:688373
Watchlist
Price: 5.13 CNY -7.73%
Market Cap: 2.2B CNY
Have any thoughts about
Shanghai MicuRx Pharmaceutical Co Ltd?
Write Note

Shanghai MicuRx Pharmaceutical Co Ltd
Cash Taxes Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai MicuRx Pharmaceutical Co Ltd
Cash Taxes Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Taxes Paid CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai MicuRx Pharmaceutical Co Ltd
SSE:688373
Cash Taxes Paid
ÂĄ9.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash Taxes Paid
-ÂĄ579.2m
CAGR 3-Years
-38%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash Taxes Paid
-ÂĄ145.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash Taxes Paid
-ÂĄ537.3m
CAGR 3-Years
-55%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash Taxes Paid
-ÂĄ2.7B
CAGR 3-Years
-13%
CAGR 5-Years
-33%
CAGR 10-Years
-44%
Imeik Technology Development Co Ltd
SZSE:300896
Cash Taxes Paid
-ÂĄ416.7m
CAGR 3-Years
-69%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
No Stocks Found

Shanghai MicuRx Pharmaceutical Co Ltd
Glance View

Market Cap
2.2B CNY
Industry
Biotechnology

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. The company is headquartered in Shanghai, Shanghai and currently employs 179 full-time employees. The company went IPO on 2022-08-05. The firm's antibacterial drug product, contezolid tablets, can be applied to treat infections caused by multidrug-resistant gram-positive bacteria. The firm also has a number of new anti-drug-resistant bacteria, kidney cancer, nephritis drugs and anti-new crown drug pipelines in the preclinical stage, including MRX-4, MRX-5, MRX-7, MRX-15, MRX-17 and others. The firm operates its businesses primarily in the domestic market.

Intrinsic Value
5.58 CNY
Undervaluation 8%
Intrinsic Value
Price
S

See Also

What is Shanghai MicuRx Pharmaceutical Co Ltd's Cash Taxes Paid?
Cash Taxes Paid
9.9m CNY

Based on the financial report for Dec 31, 2023, Shanghai MicuRx Pharmaceutical Co Ltd's Cash Taxes Paid amounts to 9.9m CNY.

What is Shanghai MicuRx Pharmaceutical Co Ltd's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 1Y
37%

Over the last year, the Cash Taxes Paid growth was 37%.

Back to Top